[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Boehringer Ingelheim – SWOT Framework Analysis

May 2016 | 20 pages | ID: BDE75F7EC71EN
Aruvian's R'search

US$ 110.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The company Boehringer Ingelheim is one of the 20 leading pharmaceutical companies in the world. The company specializes in pharmaceutical drugs for respiratory diseases, metabolism, oncology and immunology. The company is also active in the field of animal health and biopharmaceuticals. The company also has a huge research and development presence worldwide.

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective of the business venture or project and identifying the internal and external factors that are favorable and unfavorable to achieving that objective.

The aim of any SWOT analysis is to identify the key internal and external factors that are important to achieving the objective.

Aruvian Research analyzes Boehringer Ingelheim in a SWOT analysis and also provides a brief profile of the company in the report Boehringer Ingelheim – SWOT Framework Analysis. It is an in-depth analysis of the strengths, weaknesses, opportunities and threats that face Boehringer Ingelheim in the present-day business scenario.
A. EXECUTIVE SUMMARY

B. BOEHRINGER INGELHEIM GMBH: BRIEF PROFILE

C. BOEHRINGER INGELHEIM GMBH: SWOT FRAMEWORK ANALYSIS

C.1 Strengths to Build Upon
C.2 Weaknesses to Overcome
C.3 Opportunities to Exploit
C.4 Threats to Overcome

D. GLOSSARY OF TERMS


More Publications